You are here

Home » Content

Uzun süreli karbamazepin, fenobarbital ve valproik asid kullanımının tiroid ve paratiroid fonksiyonları üzerine etkisi

The effects of long-term carbamazepine, phenobarbital and valproic acid therapy on thyroid and parathyroid functions

Journal Name:

  • Gülhane Tıp Dergisi

Publication Year:

  • 2007

Key Words:

Keywords (Original Language):

Author Name
Abstract (2. Language): 
Carbamazepine, phenobarbital and valproic acid are used as antiepileptic drugs in many types of epilepsy. Although these antiepileptic drugs are well tolerated, it is known that they have some side effects on endocrine system. In this study, we investigated the effects of carbamazepin, phenobarbital and valproic acid treatment on thyroid and parathyroid functions of 120 cases (58 female and 62 male with ages ranging between 5 months to 14 years) followed-up with the diagnosis of epilepsy, and compared these effects with those of a control group. Complete blood count, serum levels of calcium, phosphorus, alkaline phosphatase, aspartate aminotransferase, alanine aminotransferase, free triiodothyronine, free thyroxine, thyroid stimulating hormone, parathyroid hormone and serum drug concentrations were measured in all cases. Carbamazepin and phenobarbital except for valproic acid significantly decreased free thyroxine levels. Free triiodothyronine and thyroid stimulating hormone levels did not differ significantly between the study and control groups. Parathormone levels significantly increased in the groups of phenobarbital and carbamazepine when compared to the control group. No significant differences were observed among the groups regarding serum calcium and phosphorus levels. We conclude that thyroid and parathyroid functions of patients using carbamazepine and phenobarbital for a long time should be regularly monitored.
Bookmark/Search this post with
Abstract (Original Language): 
Karbamazepin, fenobarbital ve valproik asid birçok epilepsi tipinde antiepileptik ilaç olarak kullanılmaktadır. Bu antiepileptik ilaçlar iyi tolere edilmelerine rağmen endokrin sistem üzerine bazı yan etkilerinin olduğu bilinmektedir. Bu çalışmada karbamazepin, fenobarbital ve valproik asidin tiroid ve paratiroid fonksiyonları üzerine olan etkilerini epilepsi tanısı ile izlenen ve antiepileptik tedavi alan yaşları 5 ay ile 14 yıl arasında değişen 58'i kız, 62'si erkek toplam 120 olguda araştırdık. Olguların tam kan, serum kalsiyum, fosfor, alkalen fosfataz, aspartat aminotransferaz, alanin aminotransferaz, serbest triiyodotironin, serbest tiroksin, tiroid stimülan hormon, parathormon ve ilaç kan seviyeleri ölçüldü. Valproik asid dışında karbamazepin ve fenobarbitalin serbest tiroksin düzeylerini önemli oranda düşürdüğü saptandı. Serbest triiyodotironin ve tiroid stimülan hormon düzeylerinde kontrol grubuna göre anlamlı bir farklılık yoktu. Fenobarbital ve karbamazepin kullanan olgularda parathormon seviyelerinde kontrol grubuna göre istatistiksel olarak anlamlı bir yükseklik saptandı. Serum kalsiyum ve fosfor parametreleri açısından önemli bir farklılık saptanmadı. Sonuç olarak uzun süreli karbamazepin ve fenobarbital kullanan hastaların tiroid ve paratiroid fonksiyonlarının düzenli takibini önermekteyiz.
FULL TEXT (PDF): 
PDF icon arastirmax-uzun-sureli-karbamazepin-fenobarbital-valproik-asid-kullaniminin-tiroid-paratiroid-fonksiyonlari-uzerine-etkisi.pdf
  • 4
222-225
  • Turkish

REFERENCES

References: 

1. Haslam RH. Nonfebrile seizures. Pediatr Rev 1997; 18:
39-49.
2. Aanderud S, Strandjord RE. Hypothyroidism induced by
anti-epileptic therapy. Acta Neurol Scand 1980; 61: 330-
332.
3. Staub JJ, Althaus BU, Engler H, et al. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin,
prolactin, and thyroid reserve, and metabolic impact on
peripheral target tissues. Am J Med 1992; 92: 631-642.
4. Bouillon R, Reynaert J, Claes JH, Lissens W, De Moor P.
The effect of anticonvulsant therapy on serum levels of
25-hydroxy-vitamin D, calcium, and parathyroid hormone. J Clin Endocrinol Metab 1975; 41: 1130-1135.
5. Kruse K, Bartels H, Ziegler R, Dreller E, Kracht U.
Parathyroid function and serum calcitonin in children
receiving anticonvulsant drugs. Eur J Pediatr 1980; 133:
151-156.
6. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and
Terminology of the International League Against
Epilepsy. Epilepsia 1989; 30: 389-399.
7. Bentsen KD, Gram L, Veje A. Serum thyroid hormones
and blood folic acid during monotherapy with carbamazepine or valproate. A controlled study. Acta Neurol
Scand 1983; 67: 235-241.
8. Isojarvi JI, Pakarinen AJ, Myllyla VV. Thyroid function
with antiepileptic drugs. Epilepsia 1992; 33: 142-148.
9. Isojarvi JI, Turkka J, Pakarinen AJ, Kotila M, Rattya J,
Myllyla VV. Thyroid function in men taking carbamazepine, oxcarbazepine, or valproate for epilepsy.
Epilepsia 2001; 42: 930-934.
10. Liewendahl K, Majuri H, Helenius T. Thyroid function
tests in patients on long-term treatment with various anticonvulsant drugs. Clin Endocrinol (Oxf) 1978; 8: 185-
191.
11. Strandjord RE, Aanderud S, Myking OL, Johannessen SI.
Influence of carbamazepine on serum thyroxine and triiodothyronine in patients with epilepsy. Acta Neurol
Scand 1981; 63: 111-121.
12. Verrotti A, Basciani F, Morresi S, Morgese G, Chiarelli F.
Thyroid hormones in epileptic children receiving carbamazepine and valproic acid. Pediatr Neurol 2001; 25: 43-
46.
13. Yuksel A, Kartal A, Cenani A, Yalcin E. Serum thyroid
hormones and pituitary response to thyrotropin-releasing
hormone in epileptic children receiving anti-epileptic
medication. Acta Paediatr Jpn 1993; 35: 108-112.
14. Zhu SQ, Liu XM, Ruan XZ, Cai Z. Changes of thyroid
hormone levels in epileptic patients. J Tongji Med Univ
1994; 14: 119-123.
15. Haidukewych D, Rodin EA. Chronic antiepileptic drug
therapy: classification by medication regimen and incidence of decreases in serum thyroxine and free thyroxine
index. Ther Drug Monit 1987; 9: 392-398.
16. Caksen H, Dulger H, Cesur Y, Atas B, Tuncer O, Odabas
D. Evaluation of thyroid and parathyroid functions in
children receiving long-term carbamazepine therapy. Int J
Neurosci 2003; 113: 1213-1217.
17. Larkin JG, Macphee GJ, Beastall GH, Brodie MJ. Thyroid hormone concentrations in epileptic patients. Eur J
Clin Pharmacol 1989; 36: 213-216.
18. Porter RJ. Antiepileptic drugs: historical perspective, current therapy, and clinical investigations. Prog Clin Biol
Res 1990; 361: 1-29.
19. Ericsson UB, Bjerre I, Forsgren M, Ivarsson SA.
Thyroglobulin and thyroid hormones in patients on longterm treatment with phenytoin, carbamazepine, and valproic acid. Epilepsia 1985; 26: 594-596.
20. Hahn TJ, Scharp CR, Halstead LR, Haddad JG, Karl DM,
Avioli LV. Parathyroid hormone status and renal responsiveness in familial hypophosphatemic rickets. J Clin
Endocrinol Metab 1975; 41: 926-937.
21. Schmitt BP, Nordlund DJ, Rodgers LA. Prevalence of
hypocalcemia and elevated serum alkaline phosphatase in
patients receiving chronic anticonvulsant therapy. J Fam
Pract 1984; 18: 873-877.
22. Weinstein RS, Bryce GF, Sappington LJ, King DW, Gallagher BB. Decreased serum ionized calcium and normal
vitamin D metabolite levels with anticonvulsant drug treatment. J Clin Endocrinol Metab 1984; 58: 1003-1009.
23. Reynolds EH. Chronic antiepileptic toxicity: a review.
Epilepsia 1975; 16: 319-352.
24. Tsukahara H, Kimura K, Todoroki Y, et al. Bone mineral
status in ambulatory pediatric patients on long-term antiepileptic drug therapy. Pediatr Int 2002; 44: 247-253.
25. Hoikka V, Savolainen K, Alhava EM, Sivenius J, Karjalainen P, Repo A. Osteomalacia in institutionalized epileptic patients on long-term anticonvulsant therapy. Acta
Neurol Scand 1981; 64: 122-131.
26. Tjellesen L, Gotfredsen A, Christiansen C. Effect of vitamin D2 and D3 on bone-mineral content in carbamazepine-treated epileptic patients. Acta Neurol Scand
1983; 68: 424-428.
27. Valimaki MJ, Tiihonen M, Laitinen K, et al. Bone mineral density measured by dual-energy x-ray absorptiometry
and novel markers of bone formation and resorption in
patients on antiepileptic drugs. J Bone Miner Res 1994; 9:
631-637.

Thank you for copying data from http://www.arastirmax.com